171 related articles for article (PubMed ID: 30891882)
41. Is lymph node metastasis of canine grade 2 MCTs justification for adjuvant therapy?
Schulman FY
Vet Comp Oncol; 2015 Jun; 13(2):151. PubMed ID: 25968074
[No Abstract] [Full Text] [Related]
42. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment.
Teng SP; Hsu WL; Chiu CY; Wong ML; Chang SC
Vet J; 2012 Aug; 193(2):551-6. PubMed ID: 22398132
[TBL] [Abstract][Full Text] [Related]
44. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors.
Munday JS; French AF; Gibson IR; Gwynne K
Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633
[TBL] [Abstract][Full Text] [Related]
45. The feasibility and utility of optical coherence tomography directed histopathology for surgical margin assessment of canine mast cell tumours.
Dornbusch JA; Cocca C; Jennings R; Samuelson J; Vieson M; Huang PC; Boppart SA; Wavreille VA; Selmic LE
Vet Comp Oncol; 2021 Dec; 19(4):616-623. PubMed ID: 32951309
[TBL] [Abstract][Full Text] [Related]
46. Use of neutrophil to lymphocyte ratio for predicting histopathological grade of canine mast cell tumours.
Macfarlane MJ; Macfarlane LL; Scase T; Parkin T; Morris JS
Vet Rec; 2016 Nov; 179(19):491. PubMed ID: 27650464
[TBL] [Abstract][Full Text] [Related]
47. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
48. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
Berlato D; Murphy S; Laberke S; Rasotto R
Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
[TBL] [Abstract][Full Text] [Related]
49. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
[TBL] [Abstract][Full Text] [Related]
50. Canine mast cell tumours part I: Clinical and survival outcomes.
Tamlin VS; Bottema CDK; Woolford L; Dobson EC; Kessell AE; Peaston AE
Vet Med Sci; 2022 Jul; 8(4):1409-1420. PubMed ID: 35505524
[TBL] [Abstract][Full Text] [Related]
51. Mast cell tumor in dogs--incidence and histopathological characterization.
Grabarević Z; Spoljar JB; Kurilj AG; Sostarić-Zuckermann IC; Artuković B; Hohsteter M; Beck A; Dzaja P; Strmecki NM
Coll Antropol; 2009 Mar; 33(1):253-8. PubMed ID: 19408634
[TBL] [Abstract][Full Text] [Related]
52. Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline.
Marconato L; Zorzan E; Giantin M; Di Palma S; Cancedda S; Dacasto M
J Vet Intern Med; 2014; 28(2):547-53. PubMed ID: 24372836
[TBL] [Abstract][Full Text] [Related]
53. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
54. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing.
Vozdova M; Kubickova S; Pal K; Fröhlich J; Fictum P; Rubes J
Vet Comp Oncol; 2020 Dec; 18(4):509-518. PubMed ID: 31999054
[TBL] [Abstract][Full Text] [Related]
55. A synonymous germline variant in a gene encoding a cell adhesion molecule is associated with cutaneous mast cell tumour development in Labrador and Golden Retrievers.
Biasoli D; Compston-Garnett L; Ricketts SL; Birand Z; Courtay-Cahen C; Fineberg E; Arendt M; Boerkamp K; Melin M; Koltookian M; Murphy S; Rutteman G; Lindblad-Toh K; Starkey M
PLoS Genet; 2019 Mar; 15(3):e1007967. PubMed ID: 30901340
[TBL] [Abstract][Full Text] [Related]
56. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology of Breed-Related Mast Cell Tumour Occurrence and Prognostic Significance of Clinical Features in a Defined Population of Dogs in West-Central Italy.
Pierini A; Lubas G; Gori E; Binanti D; Millanta F; Marchetti V
Vet Sci; 2019 Jun; 6(2):. PubMed ID: 31174330
[TBL] [Abstract][Full Text] [Related]
58. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
59. Transcriptomic analysis identified up-regulation of a solute carrier transporter and UDP glucuronosyltransferases in dogs with aggressive cutaneous mast cell tumours.
Giantin M; Baratto C; Marconato L; Vascellari M; Mutinelli F; Dacasto M; Granato A
Vet J; 2016 Jun; 212():36-43. PubMed ID: 27256023
[TBL] [Abstract][Full Text] [Related]
60. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
